Dergiler / Türk Kardiyoloji Derneği Arşivi / 2010 / Cilt: 38 - Sayı: 6

Akut koroner sendrom ile başvuran 70 yaş ve üzeri hastalarda invaziv tanısal yöntem tercihleri ve bunun erken dönem mortalite ile ilişkisi

Preferences regarding invasive diagnostic procedures in patients aged 70 years or over presenting with acute coronary syndrome and relationship with short-term mortality

Sayfa
393–399
Yayın Tarihi
2022-11-05
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

Amaç: Bu çalışmada, akut koroner sendrom (AKS) ile başvuran hastalar

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Amaç: Bu çalışmada, akut koroner sendrom (AKS) ile başvuran hastalar
📊
Temel Bulgular & Veri:Amaç: Bu çalışmada, akut koroner sendrom (AKS) ile başvuran hastalar
💡
Sonuç & Katkı:Amaç: Bu çalışmada, akut koroner sendrom (AKS) ile başvuran hastalar
🔬Tür:Araştırma Makalesi
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:Alan Parametreleri

Özet

Amaç: Bu çalışmada, akut koroner sendrom (AKS) ile başvuran hastalar

Abstract

Objectives: We prospectively classified patients presenting with acute coronary syndrome (ACS) into two age groups,

🔖

Bu Makaleye Atıf Yap

ÖZEN, N., KOCABAŞ, U., TOPÇUGİL, F., AKYILDIZ, Z. İ., NAZLI, C., ERGENE, O., DUYGU, H. (2022). Akut koroner sendrom ile başvuran 70 yaş ve üzeri hastalarda invaziv tanısal yöntem tercihleri ve bunun erken dönem mortalite ile ilişkisi. Türk Kardiyoloji Derneği Arşivi, Cilt: 38 - Sayı: 6, 393–399. https://ajindex.com/articles/633239

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (11)

  1. Kochanek KD, Smith BL. Deaths: preliminary data for 2002. Natl Vital Stat Rep 2004;52:1-47
  2. Wienbergen H, Gitt AK, Schiele R, Juenger C, Heer T, Vogel C, et al. Different treatments and outcomes of consecutive patients with non-ST-elevation myocardial infarction depending on initial electrocardiographic changes (results of the Acute Coronary Syndromes [ACOS] Registry). Am J Cardiol 2004;93:1543-6
  3. Praz L, Cook S, Meier B. Percutaneous coronary interventions in Europe in 2005. EuroIntervention 2008;3:442-6
  4. Eagle KA, Nallamothu BK, Mehta RH, Granger CB, Steg PG, Van de Werf F, et al. Trends in acute reperfusion therapy for ST-segment elevation myocardial infarction from 1999 to 2006: we are getting better but we have got a long way to go. Eur Heart J 2008;29:609-17
  5. Rathore SS, Mehta RH, Wang Y, Radford MJ, Krumholz HM. Effects of age on the quality of care provided to older patients with acute myocardial infarction. Am J Med 2003;114:307-15
  6. Alexander KP, Newby LK, Bhapkar MV, White HD, Hochman JS, Pfisterer ME, et al. International variation in invasive care of the elderly with acute coronary syndromes. Eur Heart J 2006;27:1558-64
  7. Pfisterer M, Buser P, Osswald S, Allemann U, Amann W, Angehrn W, et al. Outcome of elderly patients with chronic symptomatic coronary artery disease with an invasive vs optimized medical treatment strategy: one-year results of the randomized TIME trial. JAMA 2003;289:1117-23
  8. Cannon CP, Weintraub WS, Demopoulos LA, Vicari R, Frey MJ, Lakkis N, et al. Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein IIb/IIIa inhibitor tirofiban. N Engl J Med 2001; 344:1879-87
  9. Bach RG, Cannon CP, Weintraub WS, DiBattiste PM, Demopoulos LA, Anderson HV, et al. The effect of routine, early invasive management on outcome for elderly patients with non-ST-segment elevation acute coronary syndromes. Ann Intern Med 2004;141:186-95
  10. Lagerqvist B, Husted S, Kontny F, Ståhle E, Swahn E, Wallentin L, et al. 5-year outcomes in the FRISC-II randomised trial of an invasive versus a non-invasive strategy in non-ST-elevation acute coronary syndrome: a follow-up study. Lancet 2006;368:998-1004
  11. Topol EJ; GUSTO V Investigators. Reperfusion therapy for acute myocardial infarction with fibrinolytic therapy or combination reduced fibrinolytic therapy and platelet glycoprotein IIb/IIIa inhibition: the GUSTO V randomised trial. Lancet 2001;357:1905-14.